Thermo Fisher Scientific (TMO) Tops Q2 EPS by 25c; Raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Unity Software stock soars 22% on strong Q3 beat, robust guidance
- Qualcomm (QCOM) Reports In-Line Q4 EPS, Beats on Revenue; Offers Q1 Guidance
- Intel shares fall as competitor reports record results
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- SanDisk shares fall on election and chip sector pressure
- Seagate Technology shares drop amid sector selloff
- After-Hours Movers: QCOM, COHR, APP, HUBS, SNAP, FSLY, FIG, ZG, BROS, CDE
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
Thermo Fisher Scientific (TMO) PT Raised to $655 at Jefferies
July 24, 2024 4:04 PM EDTJefferies analyst Brandon Couillard raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $655.00 (from $650.00) while maintaining a Buy rating.
The analyst comments "TMO delivered solid revenue/EPS upside despite the still choppy demand backdrop. FY guidance was nudged... More
Thermo Fisher Scientific (TMO) PT Raised to $664 at RBC Capital, 'Recovery on Track'
July 24, 2024 12:39 PM EDTRBC Capital analyst Conor McNamara raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $664.00 (from $660.00) while maintaining a Outperform rating.
The analyst comments "Since taking over as the leader of TMO in 2009, CEO Marc Caspar (by our math) has hit or... More
Goldman Sachs Reiterates Buy Rating on Thermo Fisher Scientific (TMO)
July 24, 2024 7:15 AM EDTGoldman Sachs analyst Matthew Sykes reiterated a Buy rating and $650.00 price target on Thermo Fisher Scientific (NYSE: TMO).
The analyst comments "2Q24 bottom line beat with (1%) in organic growth: 2Q revenue of $10.54bn is above Visible Alpha Consensus Data of $10.52bn... More



